These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8079111)

  • 1. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
    Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colloidal bismuth subcitrate and omeprazole inhibit alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori.
    Roine RP; Salmela KS; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Life Sci; 1992; 51(21):PL195-200. PubMed ID: 1435071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of bismuth-containing compounds.
    Lambert JR
    Rev Infect Dis; 1991; 13 Suppl 8():S691-5. PubMed ID: 1925310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens.
    Chiba N
    Can J Gastroenterol; 2000 Nov; 14(10):885-9. PubMed ID: 11111112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetaldehyde and ethanol production by Helicobacter pylori.
    Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Scand J Gastroenterol; 1994 Apr; 29(4):309-12. PubMed ID: 8047804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of nitecapone.
    Slomiany BL; Piotrowski J; Rajiah G; Slomiany A
    Gen Pharmacol; 1991; 22(6):1063-9. PubMed ID: 1839788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro.
    Huesca M; Gold B; Sherman P; Lewin P; Lingwood C
    Zentralbl Bakteriol; 1993 Sep; 280(1-2):244-52. PubMed ID: 8280948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
    Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
    J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.
    Murty VL; Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 May; 26(6):1091-9. PubMed ID: 1632804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori.
    Meyer JM; Ryu S; Pendland SL; Danziger LH
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1607-8. PubMed ID: 9210696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eradication of Helicobacter pylori in patients with recurrent abdominal pain using a triple drug treatment].
    Ramírez Mayans J; Zamora Dávila E; Cervantes Bustamante R; Mata Rivera N; Oyervides García CI; Cuevas Schacht F; Sosa de Martínez MC
    Rev Gastroenterol Mex; 1996; 61(4):310-3. PubMed ID: 9072781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy.
    Phillips RH; Whitehead MW; Lacey S; Champion M; Thompson RP; Powell JJ
    Helicobacter; 2000 Sep; 5(3):176-82. PubMed ID: 10971684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an ammonia electrode for rapid quantification of Helicobacter pylori urease: its use in the endoscopy room and in the assessment of urease inhibition by bismuth subsalicylate.
    Butcher GP; Ryder SD; Hughes SJ; Stewart M; Bird N; Haqqani MT; Rhodes JM
    Digestion; 1992; 53(3-4):142-8. PubMed ID: 1291402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between clindamycin and colloidal bismuth subcitrate against Helicobacter (Campylobacter) pylori in vitro.
    Vogt K; Hahn H
    Zentralbl Bakteriol; 1990 Nov; 274(2):246-9. PubMed ID: 2085373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.
    Marcus EA; Sachs G; Scott DR
    Aliment Pharmacol Ther; 2015 Oct; 42(7):922-33. PubMed ID: 26238858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori--a possible mechanism behind gastric injury.
    Roine RP; Salmela KS; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Life Sci; 1992; 51(17):1333-7. PubMed ID: 1406052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mode of action of colloidal bismuth subcitrate.
    Lee SP
    Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs.
    Wagner S; Beil W; Mai UE; Bokemeyer C; Meyer HJ; Manns MP
    Pharmacology; 1994 Oct; 49(4):226-37. PubMed ID: 7831386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.